Data in Brief · 2020 · 21 citations · 4 references
MedicineHematologyClinical BiochemistryHemostasisInflammationCoagulation AbnormalitiesCoagulation DisordersCoagulation PhysiologyThrombin GenerationThrombosisThrombotic DisordersCoagulationElectronic Clinical ReportsFactor Viii ActivationProthrombin ActivationThrombin Generation AssaysThrombin TimeThrombosis MechanismsVon Willebrand Factor Antigen
This data article accompanies the manuscript entitled: “Prothrombotic Disturbances of hemostasis of Patients with Severe COVID-19: a Prospective Longitudinal Observational Cohort Study” submitted to Thrombosis Research by the same authors. We report temporal changes of plasma levels of an extended set of laboratory parameters during the ICU stay of the 21 COVID-19 patients included in the monocentre cohort: CRP, platelet count, prothrombin time; Clauss fibrinogen and clotting factors II, V and VIII levels, D-dimers, antithrombin activity, protein C, free protein S, total and free tissue factor pathway inhibitor, PAI-1 levels, von Willebrand factor antigen and activity, ADAMTS-13 (plasma levels); and of two integrative tests of coagulation (thrombin generation with ST Genesia) and fibrinolysis (global fibrinolytic capacity - GFC). Regarding hemostasis, we used double-centrifuged frozen citrated plasma prospectively collected after daily performance of usual coagulation tests. Demographic and clinical characteristics of patients and thrombotic and hemorrhagic complications were also collected from patient's electronic medical reports.
4
Scott Kaatz, Alex C. Spyropoulos, Sam Schulman · Journal of Thrombosis and Haemostasis · 2015 · 1.4K citations
Koji Suzuki, Hideo Wada, Hiroshi Imai et al. · Journal of Thrombosis and Haemostasis · 2018 · 96 citations · Full text
Sara Calzavarini, Justine Brodard, Claudia Quarroz et al. · Research and Practice in Thrombosis and Haemostasis · 2019 · 63 citations · Full text